Clinical trial Recruiting at 1 site Interventional Ages 18 to 85 Women only

Prehabilitation within ERAS for gynecologic oncology surgery

Official title: Prehabilitation With Exercise and Immunonutrition (Ocoxin®) in the Perioperative Management of Gynecologic Malignancies Under ERAS Protocol.

Run by Aristotle University Of Thessaloniki · NCT07210164 · Data updated 2026-11-12

This trial tests whether a pre-surgery program of tailored exercise, immunonutrition (Ocoxin), breathing exercises and psychological support combined with ERAS helps people having gynecologic cancer surgery recover faster and with fewer complications.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexWomen only
Enrollment100 (estimated)
SponsorAristotle University Of Thessaloniki
Academic / other
Locations1 site (Thessaloniki)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 30, 2029
Study endsDecember 30, 2029
Registry record updatedOctober 7, 2025
Trial IDNCT07210164 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 with endometrial, ovarian, or cervical cancer planned for laparotomy who are ASA I–III, speak Greek, and consent to ERAS and study participation are ideal candidates.

Probably not a fit

Patients with poor functional status (ECOG >2 or ASA >III), those not undergoing laparotomy, or those unable to provide informed consent or follow the Greek-language program are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants scheduled for open gynecologic cancer surgery (laparotomy) will be offered a multifactorial prehabilitation program delivered before operation alongside the hospital's Enhanced Recovery After Surgery (ERAS) pathway. The program includes structured self-guided exercise, immunonutrition (Ocoxin), respiratory training and psychological preparation. Outcomes include quality of life, days in hospital, immediate and 40-day postoperative complications graded by the Clavien-Dindo system, readmission rates, and postoperative morbidity and mortality. The study compares implementation of the prehabilitation protocol versus non-implementation in eligible patients at the participating center.

Why it matters

Potential benefit: If successful, this approach could shorten hospital stays, lower complication and readmission rates, and improve post-surgery quality of life for women having gynecologic cancer operations.

How similar studies have gone: ERAS protocols have repeatedly improved recovery in gynecologic surgery and prehabilitation has shown benefit in other surgical specialties, but multifactorial prehabilitation with immunonutrition in gynecologic oncology remains less well-studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Type of gynecological malignancy: endometrial cancer, ovarian cancer, cervical cancer, treated with laparotomy after the decision of the gynecological-oncology unit (positive opinion of the Multidisciplinary Tumor Board - MDT)
* Patient age: 18 to 85 years
* General condition of the patient: ASA score I-III
* Consent to implement the accelerated recovery protocol - Enhanced recovery after surgery (ERAS)
* Sufficient understanding of the Greek language
* Provision of signed, after thorough information, consent to participate in the study

Exclusion Criteria:

* Women with performance status: ECOG \>2 and ASA score \>III
* Women who have not been informed and have given written consent

Where it's running

  • General Hospital of Papageorgiou
    Thessaloniki, Greece
    Recruiting

Study contacts

  • Principal investigator: Panagiotis M. Tzitzis, MD, MSc — PhD (c) 1st Department of Obstetrics - Gynaecology Aristotel University of Thessaloniki
  • Study coordinator: Dimitrios Tsolakidis C. MD, PhD, Professor OB&GYN
  • Email: dtgyn@auth.gr
  • Phone: +30 2313 32 3380

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.